Sun, Siyu
Feng, Zhiyu
Na, Weilan
Gao, Yuan
Min, Shaojie
Zhuang, Quannan
Lin, Siyi
Zhao, Quming
Huang, Xianghui
Song, Hongmei
Sheng, Wei https://orcid.org/0000-0003-0145-3258
Huang, Guoying
Funding for this research was provided by:
National Key Research and Development Program of China (2021YFC2701000)
National Natural Science Foundation of China (no.82470314)
National Natural Science Foundation of China (82270312)
Major Special Project of Xiamen Health High Quality Development Science and Technology Plan (No.2024GZL-ZD06)
Xiamen Natural Science Foundation Project (No. 3502Z202373137)
Science and Technology Projects of Xizang Autonomous Region, China (No. XZ202401ZY0042)
CAMS Innovation Fund for Medical Sciences (2019-I2M-5-002)
Article History
Received: 30 October 2025
Revised: 18 January 2026
Accepted: 7 February 2026
First Online: 9 July 2026
Declarations
:
: The authors declare no competing interests.
: All human stem cell research followed the ISSCR Guidelines for the Conduct of Human Embryonic Stem Cell Research. The human embryonic stem cell (hESC) line H7 used in this study was obtained from the WiCell Research Institute under a specific Material Transfer Agreement (MTA). All experiments were performed in compliance with the relevant institutional and international ethical regulations.
: The authors confirm that informed consent for publication was obtained from all participants.
: All the participants provided written informed consent.